IN-DATE
1174118: Bard PowerPICC 4F Single-Lumen Catheter w/Sherlock 3CG TPS Stylet, Max Barrier
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $179.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 1 eaches |
| Expiration: | 08-2026 |
| Express: | Need it tomorrow? Order in next 16 hours 38 minutes and choose overnight shipping at checkout. |
Additional Details
BD Bard PowerPICC 4F Single-Lumen Catheter w/Sherlock 3CG TPS Stylet, Max Barrier
1174118
- Single-Lumen PICC w/Sherlock 3CG TPS Stylet/T-Lock Assembly
- StatLock
- Safety Peripheral IV Catheter
- End Cap
- ECG Leads Assembly
- ECG Electrodes
- Blue Elastic Band
- Remote Control Holder
- Safety Scalpel
- Introducer Needle
- MicroEZ Microintroducer
- Flexura Guidewire
- Sherlock Sensor Holder
AccessGUDID Info
- FDA Product Code: LJS
- FDA Product Code Name: Catheter,intravascular,therapeutic,long-term greater than 30 days
- GMDN Term Code: 36257
- GMDN Term Name: Peripherally-inserted central venous catheter
- GMDN Term Description: A thin, flexible tube intended to be introduced into a peripheral vein and advanced to a central vein for short- to long-term intravascular access to administer medications (antibiotics), chemotherapeutic agents, nutrients, parenteral solutions, pain management fluids, and sometimes for blood sampling, monitoring of blood pressure and temperature, and for power injection of contrast media; it is not primarily intended for extracorporeal blood therapies such as haemodialysis. Also known as a peripherally inserted central catheter (PICC), it typically includes dedicated accessories to facilitate catheter introduction/function (e.g., Luer hubs, stylet). This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
